Philadelphia, Pennsylvania, United States, January 2026 – Prakash Chhugani has taken on the role of Head of Commercial Enablement for US Vaccines at GSK, continuing his journey with the organization as he helps strengthen commercial readiness and execution for GSK’s vaccines portfolio in the United States. In his new role, he is expected to lead a team focused on building scalable enablement capabilities that support customer-facing excellence and advance GSK’s public health mission.
Before assuming this role, Prakash Chhugani served as Global Marketing Lead at GSK for nearly four years, where he played a central role in developing and operationalizing the launch plan for GSK’s adult RSV vaccine. His work spanned shaping value propositions and go-to-market plans, long-range forecasting governance, lifecycle prioritization and business case development, KPI and data strategy, and strategic coordination across R&D, Medical, Finance, and international markets, alongside training programs to ensure strong strategy pull-through.
Prior to joining GSK, he spent close to two decades with Sanofi (including roles associated with the vaccines business over that period), where he held senior commercial leadership positions spanning customer marketing, commercial operations, analytics & insights, product marketing, and strategic planning. His experience included leading enterprise customer marketing strategy and capability-building across digital, eCommerce, customer experience, and large customer marketing; driving commercial excellence programs impacting P&L performance; building analytics and governance capabilities; and leading major go-to-market initiatives across the vaccine portfolio.
Earlier in his career, he gained additional leadership exposure through a role as Project Lead & Advisor to the Chief Operating Officer at Lahey Clinic Medical Center, adding cross-functional operating perspective before his long trajectory in vaccines and commercial excellence.
About GSK
GSK is a focused biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. The company aims to significantly expand its impact on global health through innovation across vaccines and specialty medicines, supported by teams working across therapeutic areas and infectious diseases.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
